Brought to you by:
VAM 2022 Opening Ceremony: ‘Our Society is what it is because of you,’ SVS members hear
From the first Vascular Annual Meeting (VAM) that featured just eight papers, to VAM 2022 with many more times that number of presentations, each gathering through this year’s 75th edition has featured research, friendships and the desire to improve patient…
First results from BEST-CLI poised to reveal ‘very low’ quality of life for patients entering the trial, especially women
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual Meeting (VAM) demonstrated patient-specific variables such as self-reported female gender, current smoking, impaired mobility and opioid…
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury patients
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients with traumatic brain injury (TBI), a new study presented at the 2022 Vascular Annual Meeting (VAM)…
Diversity in care: ‘From being exclusive to more inclusive’
The role diversity played in the past, how it functions in the present, and where it might take vascular surgery in the future formed one of the central themes running through the Presidential Address delivered by outgoing Society for Vascular…
New findings support benefits of structured discharge approach for post-discharge transition of care
Researchers have found that restructuring the discharge process of a vascular surgery service decreased escalation to clinical staff from an automated post-discharge phone call and improved early post-discharge visits. Thirty-day readmission rates remained unchanged despite these efforts, however, and was…
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behavior therapy for IC
A mobile phone-administered, home-based exercise therapy program for patients with intermittent claudication (IC) incorporating cognitive behavior therapy (CBT) was found to be feasible, with 78% of participants completing the whole course, the 2022 Vascular Annual Meeting (VAM) heard. The findings…
Humacyte provides update on patients treated at front-line hospitals in Ukraine with the Human Acellular Vessel for repair of vascular trauma injuries
Humacyte today announced that the first Ukrainian patients have received implants of the Human Acellular Vessel (HAV) for the treatment of vascular trauma injuries. The implants are part of Humacyte’s humanitarian relief initiative to provide investigational HAVs to multiple front-line…
Carotid stenting demonstrates comparable short- and long-term results to endarterectomy
Pooled patient-level data from more than 2,500 asymptomatic, non-octogenarian subjects have shown that carotid artery stenting (CAS) achieved comparable short- and long-term results to carotid endarterectomy (CEA). The findings of this analysis have been published by Jon Matsumura (University of…
Eagleton and Shutze: SVS members elect new vice president, secretary
The Society for Vascular Surgery (SVS) announced that Matthew Eagleton, MD, has been elected as the organization’s next vice president. The news was revealed during the SVS Annual Business Meeting, which took place on Saturday, June 18, in Boston during…
Getting the most out of meetings like VAM
It’s Friday at Vascular Annual Meeting (VAM) 2022 in Boston! Hopefully, many of us trainees are getting to mingle and meet leaders in the field in addition to other trainees outside of our usual orb. In his 2020 Vascular and…